|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105 IDR | -3.67% |
|
-10.26% | -90.83% |
| 05-10 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
| 03-15 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Pyridam Farma Tbk reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was IDR 520,474.72 million compared to IDR 550,922.64 million a year ago. Net loss was IDR 45,496.61 million compared to net income of IDR 288,756.94 million a year ago.
Basic loss per share from continuing operations was IDR 85.03 compared to basic earnings per share from continuing operations of IDR 539.65 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -90.83% | 71.94M | |
| +41.64% | 630B | |
| -7.15% | 350B | |
| +18.77% | 328B | |
| +8.79% | 298B | |
| +17.55% | 246B | |
| +0.20% | 225B | |
| +10.39% | 218B | |
| +3.68% | 160B | |
| -4.38% | 156B |
PT PYRIDAM FARMA TBK 